Hangzhou Alltest Biotech Co., Ltd. (SHA:688606)

Hangzhou Alltest Biotech Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 18, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,995	4,909	5,362	5,519	6,631	-
Market Cap Growth	24.46%	-8.43%	-2.86%	-16.76%	-	-
Enterprise Value	2,451	2,259	2,648	2,003	4,130	-
Last Close Price	64.15	61.91	63.69	59.15	67.64	-
PE Ratio	15.90	16.23	29.69	4.66	8.66	-
PS Ratio	5.71	5.67	7.10	1.63	3.54	-
PB Ratio	1.27	1.26	1.40	1.32	2.03	-
P/TBV Ratio	1.30	1.30	1.44	1.36	2.04	-
P/FCF Ratio	74.27	45.10	-	5.06	8.46	-
P/OCF Ratio	16.59	14.90	216.51	4.06	7.18	-
EV/Sales Ratio	2.80	2.61	3.51	0.59	2.21	-
EV/EBITDA Ratio	8.35	8.48	22.03	1.45	4.88	-
EV/EBIT Ratio	9.42	9.39	26.74	1.48	4.93	-
EV/FCF Ratio	36.45	20.75	-	1.84	5.27	-
Debt / Equity Ratio	0.00	0.00	0.01	0.01	0.01	-
Debt / EBITDA Ratio	0.01	0.02	0.17	0.02	0.04	-
Debt / FCF Ratio	0.06	0.04	-	0.02	0.05	-
Asset Turnover	0.21	0.21	0.17	0.78	0.73	1.53
Inventory Turnover	2.38	2.25	1.99	5.41	3.33	2.29
Quick Ratio	10.62	9.06	10.57	7.76	4.53	4.86
Current Ratio	11.70	9.91	11.53	8.20	5.14	5.75
Return on Equity (ROE)	8.20%	7.85%	4.51%	31.85%	36.06%	107.31%
Return on Assets (ROA)	3.90%	3.62%	1.41%	19.45%	20.29%	67.66%
Return on Capital (ROIC)	4.16%	3.88%	1.54%	22.56%	24.44%	79.30%
Return on Capital Employed (ROCE)	6.60%	6.20%	2.60%	32.40%	25.40%	82.60%
Earnings Yield	6.38%	6.16%	3.37%	21.47%	11.55%	-
FCF Yield	1.35%	2.22%	-9.49%	19.76%	11.82%	-
Dividend Yield	4.72%	4.85%	2.35%	11.42%	4.00%	-
Payout Ratio	72.96%	76.92%	292.78%	18.20%	14.08%	-
Buyback Yield / Dilution	0.33%	0.02%	0.07%	-5.96%	-25.16%	0.10%
Total Shareholder Return	5.05%	4.87%	2.43%	5.46%	-21.16%	0.10%

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.